A new version of the DAIDS Protocol/Sample Informed Consent Template—General Use template is available on the NIAID website. This template was updated to:

1. Ensure consistency with the revised Common Rule, related policies, and best practices
2. Address data-sharing issues, including what type of information may be shared and with whom, and related country-specific consent requirements
3. Include co-enrollment prevention/age and identity verification process information (see the SCORE Manual)

This template is intended to be used a tool to the Requirements for Informed Consent Forms policy.

The following three policies and SOP are now updated and available on the NIAID website:

1. Requirements for Laboratories Performing Testing for DAIDS-Supported and/or Sponsored Clinical Trials
2. Guidance to Investigators Participating in DAIDS-Sponsored Clinical Trials-Requirements for U.S. Laboratories
3. Guidance to Investigators Participating in DAIDS-Sponsored Clinical Trials-Requirements for Non-U.S. Laboratories
4. Destruction of Clinical Research Specimens Owned by NIAID/DAIDS SOP